Search Results 501-510 of 18036 for progesterone
Patients must have had estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 (HER2) status by immunohistochemistry [IHC] and ...
The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer patients ...
Below are current clinical trials. 29 studies in Obstetrics and Gynecology (open studies only). Filter this list of studies by location, status and more.
Find out about this major life change and learn how to manage hot flashes and other menopause symptoms.
Estrogen/progesterone receptor positive OR negative disease allowed. Patients must have measurable disease per the Response Evaluation Criteria in Solid ...
eligible. - Participants must have documentation of estrogen receptor (ER) and progesterone receptor (PR) testing by IHC according to local institutional ...
Injectable single hormone, oral hormonal contraceptive (e.g., combined or progesterone only), contraceptive medication patch, or estrogen/progestin vaginal ring ...
To fulfil the requirement of HR+ disease, a breast cancer must express ER with or without co-expression of progesterone receptor. Metastatic or locally ...
In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand ...
JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.